4Kohansal R,Martinez-Camblor P,Agustí A,et al.The natural history of chronic airflow obstruction revisited:an analysis of the Framingham offspring cohort.Am J Respir Crit Care Med,2009,180:3-10.
5Parimon T,Chien JW,Bryson CL,et al.Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2007,175:712-719.
6Kiri VA,Fahbri LM,Davis K J,et al.Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.Respir Med,2009,103:85-90.
7Barceló B,Pons J,Ferrer JM,et al.Phenotypic characterisation of T-lymphocytes in COPD:abnormal CD4 + CD25 + regulatory T-lymphocyte response to tobacco smoking.Eur Respir J,2008,31:555-562.
8Isajevs S,Taivans I,Strazda G,et al.Decreased FOXP3 expression in small airways of smokers with COPD.Eur Respir J,2009,33:61-67.
9Ishibashi Y,Tanaka S,Tajima K,et al.Expression of Foxp3 in non-small cell lung cancer patients is significantly higher in tumor tissues than in normal tissues,especially in tumors smaller than 30 mm.Oncol Rep,2006,15:1315-1319.
10Shimizu K,Nakata M,Hirami Y,et al.Tumor-infiltrating.Foxp3 + regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.J Thorac Oncol,2010,5:585-590.
